SEARCH VEGSOURCE:

 

 

Follow Ups | Post Followup | Back to Discussion Board | VegSource
See spam or
inappropriate posts?
Please let us know.
  




From: TSS ()
Subject: Re: MEDICAL IMPLANTS CONTAINING BOVINE MATERIAL FROM BSE GBR III COUNTRIES I.E. USA
Date: February 19, 2006 at 12:27 pm PST

In Reply to: MEDICAL IMPLANTS CONTAINING BOVINE MATERIAL FROM BSE GBR III COUNTRIES I.E. USA posted by TSS on February 18, 2006 at 8:24 am:

Extract from Medicine MCA Questionnaire Summary From March 1989 into animal
parts in Medicines.

snip...

4.2 Oral

(not readable) and single plant preparation pills.

(not readable) VITAMIN B 12 absorption test kit which contains BOVINE
ALBUMIN. ...

http://www.bseinquiry.gov.uk/files/yb/1988/09/00003001.pdf


key thought here for those concerned about these B 12 shots would be source
of ALBUMIN and low dose long incubation as in the low dows of 38 years igCJD
case here...tss


Creutzfeldt-Jakob disease 38 years after diagnostic use
of human growth hormone

E A Croes, G Roks, G H Jansen, P C G Nijssen, C M van Duijn
...............................................................

J Neurol Neurosurg Psychiatry 2002;72:792-793

A 47 year old man is described who developed pathology
proven Creutzfeldt-Jakob disease (CJD) 38 years after
receiving a low dose of human derived growth hormone
(hGH) as part of a diagnostic procedure. The patient
presented with a cerebellar syndrome, which is compatible
with iatrogenic CJD. This is the longest incubation period
described so far for iatrogenic CJD. Furthermore, this is the
first report of CJD after diagnostic use of hGH. Since the
patient was one of the first in the world to receive hGH,
other cases of iatrogenic CJD can be expected in the coming
years............snip...........tss

COMMERCIAL IN CONFIDENCE

NOT FOR PUBLICATION

COMMITTEE ON SAFETY OF MEDICINES

CSM/SEAR/88/10TH MEETING

BIOLS/88/6TH MEETING

snip FULL TEXT 37 PAGES...tss


http://www.bseinquiry.gov.uk/files/yb/1988/09/00003001.pdf


TSS




Follow Ups:



Post a Followup

Name:
E-mail: (optional)
Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL: